Skip to main content

Cochlear

Cochlear Limited is an Australian medical device company that designs, manufactures, and distributes implantable hearing solutions globally. The company produces cochlear implants, acoustic implants, bone conduction systems, sound processors, and wireless accessories designed to address moderate to profound hearing loss. Primary revenues are generated from the sale of implant systems, sound processor upgrades, replacement parts, and clinical support services. Cochlear serves audiologists, ENT surgeons, healthcare institutions, and hearing-impaired patients across North America, Europe, Asia-Pacific, and emerging markets. The enterprise holds a dominant global market position in the implantable hearing device sector, holding significant market share worldwide. Cochlear Limited is headquartered in Sydney, Australia, and its common shares are listed on the Australian Securities Exchange.

17 of the funds FundTelligence covers report a position in Cochlear.

Legal name
Cochlear Ltd.
Sector
Health Care
Country
Australia
Funds holding it
17
Exposure themes
Ageing & Longevity, Healthy Ageing & Function, Hearing

Funds holding Cochlear

Showing the 8 largest of 17 funds holding it.

Loading...